Table 1.

List of schedules evaluated for co-administration of rotavirus and other vaccines

	Neonatal dose schedule	Booster dose schedule	Age-restricted scenario*	Age-unrestricted scenario
BCG	Yes	No	Yes	Yes
DTP1	No	No	Yes	Yes
BCG plus DTP1	Yes	No	Yes	Yes
BCG plus DTP2	Yes	No	Yes	Yes
BCG plus DTP3	Yes	No	Yes	Yes
DTP1 plus DTP2†	No	No	Yes	Yes
DTP1 plus DTP3	No	No	Yes	Yes
BCG plus DTP1 plus DTP2‡	Yes	No	Yes	Yes
BCG plus DTP1 plus DTP3	Yes	No	Yes	Yes
BCG plus DTP2 plus DTP3	Yes	No	Yes	Yes
DTP1 plus DTP2 plus DTP3†	No	No	Yes	Yes
BCG plus Meas1	Yes	Yes	No	Yes
DTP1 plus Meas1	No	Yes	No	Yes
BCG plus DTP1 plus Meas1	Yes	Yes	No	Yes
BCG plus DTP2 plus Meas1	Yes	Yes	No	Yes
BCG plus DTP3 plus Meas1	Yes	Yes	No	Yes
DTP1 plus DTP2 plus Meas1§	No	Yes	No	Yes
DTP1 plus DTP3 plus Meas1	No	Yes	No	Yes

DTP=diphtheria–tetanus–pertussis. Meas=measles vaccine.

^*First vaccination before 15 weeks of age; final vaccination before 32 weeks of age.

^†Schedules recommended by WHO; the three-dose schedule has been evaluated in efficacy trials for Rotarix, RotaTeq, ROTAVAC, ROTASIIL, and RV3-BB; the two-dose schedule has been evaluated in Rotarix efficacy studies.7

^‡Schedule evaluated in RV3-BB efficacy study in Indonesia.¹³

^§Schedule evaluated in Rotarix immunogenicity studies in Bangladesh¹⁵ and Mali.¹⁴